Candidiasis: Changes and Challenges in Its Epidemiology, Pathogenesis, Diagnosis, Treatment and Prevention
A special issue of Journal of Fungi (ISSN 2309-608X). This special issue belongs to the section "Fungal Pathogenesis and Disease Control".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 85
Special Issue Editor
Interests: medical mycology; mycoses; candida; candidiasis; mycobiome; biofilms; diagnosis; antifungal agents
Special Issue Information
Dear Colleagues,
Candidiasis presents a serious threat to public health and is associated with prolonged hospitalizations and considerable morbidity and mortality rates. The epidemiology of candidiasis has changed significantly in recent decades. Candida albicans remains the most frequent etiology, but its relative prevalence has decreased. Candidozyma auris (Candida auris) is a new emerging antifungal resistant species, with a great capacity for persistence and nosocomial transmission, causing candidiasis outbreaks in hospitals worldwide. For these reasons, the World Health Organization has included both species in their list of priority fungal pathogens. Candidiasis caused by C. albicans and C. auris have similarities, but there are also important differences in their epidemiology, pathogenesis, diagnostics and therapeutics. The aim of this Special Issue is to provide the latest knowledge on candidiasis induced by both species to improve the diagnostic and therapeutic management of these patients through comprehensive reviews, original studies, and novel perspectives.
Prof. Dr. Guillermo Quindos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medical mycology
- mycoses
- candida
- candidiasis
- mycobiome
- biofilms
- diagnosis
- antifungal agents
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
